Featured

April 21, 2023

Oxford PharmaGenesis honoured with prestigious King's Award for Enterprise

Oxford PharmaGenesis has been honoured with the first ever King’s Award for Enterprise, the most prestigious business award in the country, which recognizes the company’s excellence in International Trade.

The King’s Awards celebrate the success of exciting and innovative businesses, which are leading the way with pioneering products or services, delivering impressive social mobility programmes or showing their commitment to excellent sustainable development practices.

All
  • All
  • News
  • Articles
  • Events
Learning at work week

Learning at Work Week: Oxford PharmaGenesis focuses on supporting colleagues' development

Oxford PharmaGenesis is celebrating another brilliant Learning at Work Week (15–19 May) that has provided colleagues with a packed programme of professional and personal development opportunities.

Continue reading

Celebrating 5 years of working with Asia Pacific clients through our Melbourne office

With a strong biotech and pharmaceutical sector, Melbourne, Australia was the ideal city in which to establish an Oxford PharmaGenesis base for Asia Pacific (APAC). Since 2018, the Melbourne office has seen brilliant growth and success with APAC clients. This year, we celebrate its fifth anniversary and the journey so far. Our Melbourne office opened…

Continue reading
Medical affairs

Enabling Medical Affairs professionals to lead: highlights from the Medical Affairs Professional Society (MAPS) EMEA 2023 workshop on integrated evidence generation planning

Oxford PharmaGenesis colleagues delivered a workshop on integrated evidence generation planning (IEGP) to Medical Affairs professionals at this year’s MAPS EMEA conference (Lisbon) in May. With a holistic and systematic approach, IEGP addresses many common challenges found in evidence generation planning.

Continue reading
ISMPP

Tomas Rees, Oxford PharmaGenesis Director of Innovation, elected as Chair-Elect of the ISMPP Board of Trustees

We are proud to announce that Tomas Rees, Director of Innovation at Oxford PharmaGenesis, has been elected as the Chair-Elect for the ISMPP Board of Trustees. This is a prestigious and influential position that reflects Tomas’s expertise and leadership in the field of medical communications.

Continue reading
Digital Health

Digital health products: unique challenges and exciting opportunities

Digital health products are transforming the healthcare landscape and providing patients with new ways to manage and treat conditions. However, they come with several important considerations for medical communicators, especially when compared with traditional pharmaceuticals, explains Principal Medical Writer Caroline Leitschuh.

Continue reading

Oxford PharmaGenesis honoured with prestigious King's Award for Enterprise

Oxford PharmaGenesis has been honoured with the first ever King’s Award for Enterprise, the most prestigious business award in the country, which recognizes the company’s excellence in International Trade.

Continue reading